Pfizer to appeal over India drug patent refusal New York Daily News According to Pfizer representatives, the court's decision undermines intellectual property rights in India. Indian pharmaceutical company Cipla opposed the granting of the domestic patent for Prizer's Sutent, which is used to combat liver and kidney ... |
